Genzyme Transgenics, Novopharm Biotech Inc. deal

GZTC will produce human monoclonal antibodies for NVO's product needs. GZTC's transgenic technology, which expresses specific proteins in animal milk, can produce MAbs at a level 10-to-100 times great...